{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:15:46Z","timestamp":1778681746717,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["201700169"],"award-info":[{"award-number":["201700169"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2017\/700717-0"],"award-info":[{"award-number":["2017\/700717-0"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.026","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T10:19:34Z","timestamp":1571912374000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran"],"prefix":"10.1016","volume":"38","author":[{"given":"Seyed Mohsen","family":"Zahraei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talat","family":"Mokhtari-Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0496-7847","authenticated-orcid":false,"given":"Shahrokh","family":"Izadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Sabouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.026_b0005","unstructured":"World Health Organization. Regional Office for the Eastern Mediterranean. Eastern Mediterranean vaccine action plan 2016\u20132020: a framework for implementation of the global vaccine action plan\/World Health Organization. WHO-EM\/EPI\/353\/E. https:\/\/apps.who.int\/iris\/handle\/10665\/311578?show=full; 2019 [accessed July 2019]."},{"key":"10.1016\/j.vaccine.2019.10.026_b0010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/21645515.2018.1436920","article-title":"Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran","volume":"14","author":"Izadi","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.026_b0015","series-title":"Iran and Turkey launch world's largest measles campaigns. Press release","author":"Personnaz","year":"2003"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.10.026_b0020","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/infdis\/jir076","article-title":"Successful control and impending elimination of measles in the Islamic Republic of Iran","volume":"204","author":"Zahraei","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0025","first-page":"1","article-title":"Reiteration of the elimination status of measles in the southeast of Iran","volume":"2018","author":"Izadi","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.026_b0030","doi-asserted-by":"crossref","first-page":"e55043","DOI":"10.1371\/journal.pone.0055043","article-title":"Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign","volume":"8","author":"Honarvar","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2019.10.026_b0035","article-title":"Sero-epidemiological evaluation of rubella immunity among pre-marriage women in Iran","author":"Zahraei","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.026_b0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/cix510","article-title":"Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose","volume":"65","author":"Carazo Perez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0045","unstructured":"Rubella vaccines: WHO position paper. Releve epidemiologique hebdomadaire. 2011;86:301\u201316."},{"key":"10.1016\/j.vaccine.2019.10.026_b0050","unstructured":"World Health Organization. Rubella Fact Sheet. In: Organization WH, editor. Genuva 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rubella; 2018 [accessed 18 March 2018]."},{"key":"10.1016\/j.vaccine.2019.10.026_b0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/inf.1983.15.issue-4.01","article-title":"Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation","volume":"15","author":"Grillner","year":"1983","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0060","first-page":"1523","article-title":"Imported measles and implications for its elimination in Taiwan","volume":"17","author":"Cheng","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0065","unstructured":"World Health Organization Vaccination Coverage Cluster Surveys: Reference Manual World Health Organization; 2015."},{"key":"10.1016\/j.vaccine.2019.10.026_b0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2006.12.017","article-title":"Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests","volume":"38","author":"Tischer","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2019.10.026_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijid.2016.05.020","article-title":"Measles immunity among pregnant women aged 15\u201344 years in Namibia, 2008 and 2010","volume":"49","author":"Cardemil","year":"2016","journal-title":"Int J Infect Dis: IJID"},{"key":"10.1016\/j.vaccine.2019.10.026_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.10.026_b0085","unstructured":"Siemens Enzygnost Anti-Measles Virus\/IgG. Enzyme immunoassay for the qualitative detection and quantitative determination of specific IgG antibodies to measles virus in human serum and plasma. Siemens; March 2011."},{"key":"10.1016\/j.vaccine.2019.10.026_b0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1017\/S0950268807008266","article-title":"Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia","volume":"135","author":"Tischer","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.026_b0095","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1407417","article-title":"A randomized, controlled trial of an aerosolized vaccine against measles","volume":"372","author":"Low","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.026_b0100","series-title":"Design and analysis of vaccine studies","author":"Halloran","year":"2010"},{"key":"10.1016\/j.vaccine.2019.10.026_b0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/risa.12637","article-title":"Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2019.10.026_b0110","first-page":"205","article-title":"Measles vaccines: WHO position paper \u2013 April 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.10.026_b0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.26719\/2015.21.6.396","article-title":"Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran","volume":"21","author":"Izadi","year":"2015","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2019.10.026_b0120","first-page":"119","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin g avidity in measles cases during the 1997 S\u00e3o Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.10.026_b0125","first-page":"321","article-title":"Progress towards control of rubella and congenital rubella syndrome \u2013 South-East Asia Region, 2000\u20132016","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.10.026_b0130","doi-asserted-by":"crossref","first-page":"e10431","DOI":"10.5812\/ircmj.10431","article-title":"Rubella immunity in women of childbearing age, eight years after the immunization program in iran","volume":"16","author":"Barari Sawadkohi","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.vaccine.2019.10.026_b0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.15537\/1658-3175.4937","article-title":"Prevalence of rubella IgG antibodies among Syrian females of childbearing age","volume":"31","author":"Barah","year":"2010","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2019.10.026_b0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12879-016-2046-5","article-title":"Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome","volume":"16","author":"He","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0145","first-page":"419","article-title":"WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968","volume":"42","author":"Dowdle","year":"1970","journal-title":"Bull World Health Org Suppl"},{"key":"10.1016\/j.vaccine.2019.10.026_b0150","doi-asserted-by":"crossref","first-page":"812","DOI":"10.26719\/2013.19.9.812","article-title":"Seroprevalence of rubella among pregnant women in Khartoum state, Sudan","volume":"19","author":"Adam","year":"2013","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2019.10.026_b0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.26719\/2001.7.1-2.128","article-title":"Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran","volume":"7","author":"Doroudchi","year":"2001","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2019.10.026_b0160","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0950268899003222","article-title":"Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age","volume":"124","author":"Paunio","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.026_b0170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/jis719","article-title":"Measles humoral and cell-mediated immunity in children aged 5\u201310 years after primary measles immunization administered at 6 or 9 months of age","volume":"207","author":"Gans","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.026_b0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.vaccine.2012.11.014","article-title":"Waning immunity to measles in young adults and booster effects of revaccination in secondary school students","volume":"31","author":"He","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.026_b0180","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An increasing, potentially measles-susceptible population over time after vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.026_b0185","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2015.08.057","article-title":"Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal","volume":"33","author":"Goncalves","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.026_b0190","unstructured":"Immunization, Vaccination and Biologicals; Measles and Rubella Surveillance Data. World Health Organization; 2017."},{"key":"10.1016\/j.vaccine.2019.10.026_b0195","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3855\/jidc.1847","article-title":"Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India","volume":"5","author":"Sharma","year":"2011","journal-title":"J Infect Dev Ctries"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:41Z","timestamp":1778679101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19313994"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}